Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 6;14(13):2444-2454.
doi: 10.7150/jca.85695. eCollection 2023.

Differences in Colorectal Cancer Survival Based on Primary Tumor Location: Retrospective Study from a Single Institution

Manuel Diez-Alonso  1   2 , Fernando Mendoza-Moreno  1 , Miguel A Ortega  3   4 , Hector Aguado  1 , Belen Matías  1 , Cristina Vera  1 , Sonia Soto  1 , Ana Quiroga  1 , Silvestra Barrena Blazquez  5 , Melchor Alvarez de Mon  3   4   6 , Alberto Gutierrez-Calvo  1   2
Affiliations

Differences in Colorectal Cancer Survival Based on Primary Tumor Location: Retrospective Study from a Single Institution

Manuel Diez-Alonso et al. J Cancer. .

Abstract

Objective: The location of the primary tumor in colorectal cancer (CRC) could be a prognostic factor related to survival. However, its usefulness has not been sufficiently analyzed. The results in patients with tumors in initial stages are very limited, and there are descriptive parameters of survival that have not been analyzed in detail. In this study, the relationship between primary tumor location and survival in CRC patients was analyzed. Materials And Methods: This was a retrospective observational study. All patients treated consecutively for CRC between January 2005 and December 2019 in the same hospital center were included. Overall survival (OS), cancer-related survival (CRS), time to recurrence (TTR), relapse-free survival (RFS) and postrecurrence survival (PRS) were analyzed, and the results were classified by tumor stage. The results were compared among patients with right colon (RS), left colon (LS) and rectal tumors. Results: In the entire cohort, patients with RS tumors had lower OS and lower CRS at 60 months after diagnosis than did patients with LS or rectal tumors. In the regression analysis, the localization of the primary tumor was an independent prognostic indicator for OS and CRS. Analysis by tumor stage showed that patients with RS stage III tumors had lower OS and lower CRS at 60 months than did patients with LS and rectal tumors (42%, 59% and 53%, respectively, p = 0.006; and 48%, 63% and 57%, respectively, p = 0.025). Additionally, patients with RS Stage IV tumors had lower OS and lower CRS at 36 months than did patients with LS and rectal tumors (9%, 24%, 24%, respectively, p < 0.001; and 10%, 24% and 24%, respectively, p < 0.001). No differences were found in TTR and RFS among patients with stage I and II RS, LS, and rectal tumors. In contrast, patients with stage RS III tumors had significantly poorer PRS (9% for RS tumors, 13% for LS tumors, and 22% for rectal tumors) (p < 0.001). Conclusion: The location of the primary tumor in patients with CRC is related to survival. The effect of laterality is more marked in patients with stage III and IV tumors. Patients with RS tumors had lower OS and CRS due to the lower survival of patients with stage IV RS tumors and lower PRS for patients with stage III tumors.

Keywords: cancer-related survival; colorectal cancer; overall survival; relapse-free survival; survival; time to recurrence; tumor recurrence.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
Flowchart detailing the selection of the patients in this study.
Figure 2
Figure 2
Kaplan-Meier estimates of Overall Survival for the entire cohort according to localization of primary tumor.
Figure 3
Figure 3
Kaplan‑Meier survival estimates of OS according to localization of primary tumor. A. Patients with TNM Stage III, OS at 60 months after diagnosis. B. Patients with TNM Stage IV, OS at 36 months after diagnosis. Horizontal bar denotes median survival.
Figure 4
Figure 4
Kaplan‑Meier survival estimates of PRS at 36 months after recurrence according to localization of primary tumor. Horizontal bar denotes median survival.
See this image and copyright information in PMC

References

    1. Petrelli F, Tomasello G, Borgonovo K, Ghidini M, Turati L, Dallera P, Passalacqua R, Sgroi G, Barni S. Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol. 2017;3(2):211–219. - PubMed
    1. Arnold D, Lueza B, Douillard JY, Peeters HJ, Lenz A, Venook V, Heinemann E, Van Cutsem E, Pignon J, Tabernero A, Cervantes A, Ciardiello F. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomised trials. Ann Oncol. 2017;28:1713–1729. - PMC - PubMed
    1. Brule SY, Jonker DJ, Karapetis CS, Brule SY, Jonker DJ, Karapetis CS, O'Callaghan CJ, Moore MJ, Wong R, Tebbutt NC, Underhill CR, Yip D, Zalcberg JR, Tu D, Goodwin RA. Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17. Eur J Cancer. 2015; 51. 1405-1414. - PubMed
    1. Phipps AI, Buchanan DD, Makar KW, Win AK, Baron JA, Lindor NM, Potter JD, Newcomb PA. KRAS-mutation status in relation to colorectal cancer survival: The joint impact of correlated tumour markers. Br J Cancer. 2013;108:1757–1764. - PMC - PubMed
    1. Tapia Rico G, Price T, Tebbutt N, Hardingham J, Lee C, Buizen L, Wilson K, Gebski V, Townsend A. Right or Left Site of Colorectal Cancer: Outcomes from the Molecular Analysis of the AGITG Max Trial. Clinical Colorectal Cancer. 2019;8(2):141–148. - PubMed